Recent Articles

Which Hedge Fund Manager Won Q1?

Andreas Halvorsen's long stock positions as disclosed in Viking Global's latest 13F filing had a solid first quarter as they delivered an average return of 6.2% based on our calculations. More 

2 Promising Pharma Stocks to Buy

One glance at my Blue Chip Growth portfolio shows that pharmaceuticals companies have been leading the way in terms of performance. More 

Actavis Stock – Buy ACT Now That It’s Acquiring AGN

While Actavis plc (NYSE:ACT) didn't literally start in a garage, it was certainly a humble beginning for what is now the third-largest generic drug manufacturer and one of the largest pharmaceutical companies in the world. More 

2 Stocks With Acquisition Deals Worth Knowing

Of the more positive headlines, here are two acquisition announcements to give investors a view of growth and prosperity. More 

Hottest Healthcare Stocks Now – OPK CSII ICLR KERX

Healthcare stocks rose 0.5% on Wall Street today. More 

50 VIP Stocks That Matter Most

We decided to compile other VIP Stock Lists that are based on each hedge fund's top five, top three, top two and very top holdings. More 

Allergan (AGN) Stock: Keep On Buying This Botox Baron

It may be a one-trick pony, but Allergan, Inc (NYSE:AGN) has quite a trick and quite a pony. More